CLEVELAND BIOLABS INC Underwriting Agreements
2 Contracts & Agreements
- Form of Underwriting Agreement, dated March 22, 2022, by and between Statera Biopharma, Inc. and EF Hutton, a division of Benchmark Investments, LLC (Filed With SEC on March 25, 2022)
- ClevelandBioLabs, Inc. 7,500,000 Shares of Common Stock Warrants to Purchase 3,750,000 Sharesof Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 22, 2012)
